145 related articles for article (PubMed ID: 31590961)
1. Assessment of Return to Baseline Urinary and Sexual Function Following Primary Focal Cryotherapy for Nonmetastatic Prostate Cancer.
Shah TT; Peters M; Miah S; Eldred-Evans D; Yap T; Hosking-Jervis F; Dudderidge T; Hindley RG; McCracken S; Greene D; Nigam R; Valerio M; Winkler M; Virdi J; Arya M; Ahmed HU; Minhas S
Eur Urol Focus; 2021 Mar; 7(2):301-308. PubMed ID: 31590961
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Focal Therapy for Prostate Cancer on Sexual Function: A Combined Analysis of Three Prospective Trials.
Yap T; Ahmed HU; Hindley RG; Guillaumier S; McCartan N; Dickinson L; Emberton M; Minhas S
Eur Urol; 2016 May; 69(5):844-51. PubMed ID: 26525837
[TBL] [Abstract][Full Text] [Related]
3. Detailing Sexual Outcomes After Focal Therapy for Localised Prostate Cancer: A Systematic Review and Meta-analysis.
Fiard G; Chowdhury A; Potter AR; Pook CJ; Kelly D; Emberton M; Yap T
Eur Urol Focus; 2022 Jul; 8(4):926-941. PubMed ID: 34580049
[TBL] [Abstract][Full Text] [Related]
4. Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre Registry.
Shah TT; Peters M; Eldred-Evans D; Miah S; Yap T; Faure-Walker NA; Hosking-Jervis F; Thomas B; Dudderidge T; Hindley RG; McCracken S; Greene D; Nigam R; Valerio M; Minhas S; Winkler M; Arya M; Ahmed HU
Eur Urol; 2019 Jul; 76(1):98-105. PubMed ID: 30638633
[TBL] [Abstract][Full Text] [Related]
5. Recovery of Baseline Erectile Function in Men Following Radical Prostatectomy for High-Risk Prostate Cancer: A Prospective Analysis Using Validated Measures.
Sridhar AN; Cathcart PJ; Yap T; Hines J; Nathan S; Briggs TP; Kelly JD; Minhas S
J Sex Med; 2016 Mar; 13(3):435-43. PubMed ID: 26944466
[TBL] [Abstract][Full Text] [Related]
6. A comparison of time taken to return to baseline erectile function following focal and whole gland ablative therapies for localized prostate cancer: A systematic review.
Faure Walker NA; Norris JM; Shah TT; Yap T; Cathcart P; Moore CM; Ahmed HU; Emberton M; Minhas S
Urol Oncol; 2018 Feb; 36(2):67-76. PubMed ID: 29277585
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of functional outcomes after a second focal high-intensity focused ultrasonography (HIFU) procedure in men with primary localized, non-metastatic prostate cancer: results from the HIFU Evaluation and Assessment of Treatment (HEAT) registry.
Lovegrove CE; Peters M; Guillaumier S; Arya M; Afzal N; Dudderidge T; Hosking-Jervis F; Hindley RG; Lewi H; McCartan N; Moore CM; Nigam R; Ogden C; Persad R; Virdi J; Winkler M; Emberton M; Ahmed HU; Shah TT; Minhas S
BJU Int; 2020 Jun; 125(6):853-860. PubMed ID: 31971335
[TBL] [Abstract][Full Text] [Related]
8. Impact of Focal Versus Whole Gland Ablation for Prostate Cancer on Sexual Function and Urinary Continence.
Borges RC; Tourinho-Barbosa RR; Glina S; Macek P; Mombet A; Sanchez-Salas R; Cathelineau X
J Urol; 2021 Jan; 205(1):129-136. PubMed ID: 33119421
[TBL] [Abstract][Full Text] [Related]
9. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study.
Ahmed HU; Hindley RG; Dickinson L; Freeman A; Kirkham AP; Sahu M; Scott R; Allen C; Van der Meulen J; Emberton M
Lancet Oncol; 2012 Jun; 13(6):622-32. PubMed ID: 22512844
[TBL] [Abstract][Full Text] [Related]
10. Unexpected Long-term Improvements in Urinary and Erectile Function in a Large Cohort of Men with Self-reported Outcomes Following Radical Prostatectomy.
Lee JK; Assel M; Thong AE; Sjoberg DD; Mulhall JP; Sandhu J; Vickers AJ; Ehdaie B
Eur Urol; 2015 Nov; 68(5):899-905. PubMed ID: 26293181
[TBL] [Abstract][Full Text] [Related]
11. Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil Versus Placebo to Predict Recovery of Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy.
Montorsi F; Oelke M; Henneges C; Brock G; Salonia A; d'Anzeo G; Rossi A; Mulhall JP; Büttner H
Eur Urol; 2016 Sep; 70(3):529-37. PubMed ID: 26947602
[TBL] [Abstract][Full Text] [Related]
12. Erectile Function Recovery After Nerve-Sparing Radical Prostatectomy for Prostate Cancer: Is Back to Baseline Status Enough for Patient Satisfaction?
Rossi MS; Moschini M; Bianchi M; Gandaglia G; Fossati N; Dell'Oglio P; Schiavina R; Brunocilla E; Farina E; Picozzi M; Salonia A; Montorsi F; Briganti A
J Sex Med; 2016 Apr; 13(4):669-78. PubMed ID: 27045263
[TBL] [Abstract][Full Text] [Related]
13. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT).
Montorsi F; Brock G; Stolzenburg JU; Mulhall J; Moncada I; Patel HR; Chevallier D; Krajka K; Henneges C; Dickson R; Büttner H
Eur Urol; 2014 Mar; 65(3):587-96. PubMed ID: 24169081
[TBL] [Abstract][Full Text] [Related]
14. Erectile function after radical prostatectomy: Do patients return to baseline?
Fode M; Frey A; Jakobsen H; Sønksen J
Scand J Urol; 2016 Jun; 50(3):160-3. PubMed ID: 26539834
[TBL] [Abstract][Full Text] [Related]
15. Effects of Tadalafil Once-Daily or On-Demand vs Placebo on Return to Baseline Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy--Results from a Randomized Controlled Trial (REACTT).
Mulhall JP; Brock G; Oelke M; Fode M; Probst KA; Henneges C; d'Anzeo G; Rossi A; Büttner H
J Sex Med; 2016 Apr; 13(4):679-83. PubMed ID: 27045264
[TBL] [Abstract][Full Text] [Related]
16. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
[TBL] [Abstract][Full Text] [Related]
17. Long-term sexual outcomes after holmium laser enucleation of the prostate: which patients could benefit the most?
Capogrosso P; Ventimiglia E; Ferrari M; Serino A; Boeri L; Capitanio U; Briganti A; Damiano R; Montorsi F; Salonia A
Int J Impot Res; 2016 Sep; 28(5):189-93. PubMed ID: 27465782
[TBL] [Abstract][Full Text] [Related]
18. Using the Movember Foundation's GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function-a retrospective study in low-risk prostate cancer patients.
Crump RT; Remmers S; Van Hemelrijck M; Helleman J; Nieboer D; Roobol MJ; Venderbos LDF;
Transl Androl Urol; 2021 Jun; 10(6):2719-2727. PubMed ID: 34295757
[TBL] [Abstract][Full Text] [Related]
19. Long-term Outcomes of Focal Cryotherapy for Low- to Intermediate-risk Prostate Cancer: Results and Matched Pair Analysis with Active Surveillance.
Marra G; Soeterik T; Oreggia D; Tourinho-Barbosa R; Moschini M; Filippini C; van Melick HHE; van den Bergh RCN; Gontero P; Cathala N; Macek P; Sanchez-Salas R; Cathelineau X
Eur Urol Focus; 2022 May; 8(3):701-709. PubMed ID: 33926838
[TBL] [Abstract][Full Text] [Related]
20. Prospective comprehensive assessment of sexual function after retropubic non nerve sparing radical prostatectomy for localized prostate cancer.
Trinchieri A; Nicola M; Masini F; Mangiarotti B
Arch Ital Urol Androl; 2005 Dec; 77(4):219-23. PubMed ID: 16444937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
